GO:0042834 peptidoglycan binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042834 peptidoglycan binding describes the selective, non-covalent interaction of a protein with peptidoglycan, the glycoconjugate scaffold of bacterial cell walls.
• Penicillin-binding proteins (PBPs) are the archetypal peptidoglycan-binding enzymes; they recognize both the glycan strands and the peptide stems of the sacculus.
• Peptidoglycan binding is not restricted to bacteria: host peptidoglycan recognition proteins (PGRPs) and phage endolysins use dedicated binding modules to detect or degrade bacterial cell walls.
• Real-time biochemical assays and membrane-reconstituted systems now allow direct monitoring of peptidoglycan synthesis and binding by PBPs.
• Dysregulation or inhibition of peptidoglycan-binding proteins underlies beta-lactam antibiotic action and is a validated target space for new antibacterials.
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to assign causality to candidate peptidoglycan-binding genes.
Description
Peptidoglycan binding (GO:0042834) is a molecular function that describes the selective, non-covalent association of a protein with peptidoglycan, the cross-linked glycoconjugate that forms the bacterial cell wall. This function is central to bacterial growth, division and shape maintenance because the enzymes that build, remodel and hydrolyse the sacculus must first recognize and bind their polymeric substrate. The penicillin-binding proteins (PBPs) are the best-characterized peptidoglycan-binding enzymes; they catalyse the transglycosylation and transpeptidation reactions that generate the mature sacculus and are the lethal targets of beta-lactam antibiotics. Beyond bacteria, peptidoglycan binding is used by host immune receptors and bacteriophage endolysins to detect or destroy bacterial cell walls, making it a broadly relevant function across microbiology, infection biology and biotechnology. For researchers, GO:0042834 provides a precise annotation axis to distinguish genuine peptidoglycan interactors from generic carbohydrate-binding proteins. The function is experimentally defined by binding assays, structural studies and enzymatic activity measurements, and it is increasingly interrogated with real-time and membrane-reconstituted systems that report substrate engagement directly. Because peptidoglycan-binding proteins are essential in most bacteria and are absent from human cells, they remain one of the most attractive target classes for antibacterial discovery. This article summarizes the authoritative QuickGO definition, the mechanistic stages of peptidoglycan binding, the major protein families involved, disease and biotechnology relevance, and the CRISPR-based models and methods used to study this function.
peptidoglycan binding At A Glance
| GO ID | GO:0042834 |
|---|---|
| GO term | peptidoglycan binding |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Selective, non-covalent recognition of peptidoglycan, the glycoconjugate scaffold of bacterial cell walls |
| Representative proteins | Penicillin-binding proteins (PBPs), peptidoglycan recognition proteins (PGRPs), phage endolysin cell-wall binding domains |
| Substrate features | N-acetylglucosamine/N-acetylmuramic acid glycan strands and cross-linked stem peptides |
| Biological context | Bacterial cell wall synthesis, remodelling and hydrolysis; host innate immune detection; phage lysis |
| Therapeutic relevance | Beta-lactam antibiotic target space and antibacterial discovery |
What Is GO:0042834?
GO:0042834 peptidoglycan binding is defined as interacting selectively and non-covalently, in a non-covalent manner, with peptidoglycan, any of a class of glycoconjugates found in bacterial cell walls. In practice, a protein annotated with this term must physically associate with peptidoglycan through reversible, non-covalent contacts rather than through covalent catalysis or cleavage. The interaction typically involves recognition of the glycan backbone (N-acetylglucosamine and N-acetylmuramic acid repeats) and/or the stem peptides that cross-link the sacculus. This function is distinct from peptidoglycan hydrolase activity, although many enzymes combine both binding and catalytic modules.
Why Is peptidoglycan binding Important in Cell Biology?
Peptidoglycan binding is essential because the bacterial cell wall is a continuous, load-bearing polymer that must be synthesized, remodelled and hydrolysed without compromising cell integrity. Every enzyme that acts on the sacculus, including the PBPs that catalyse cross-linking, must first bind peptidoglycan, so this function sits at the heart of bacterial growth and division. The same function is exploited by host immune systems to detect bacterial infection and by bacteriophages to degrade the cell wall during lysis. Because peptidoglycan and its biosynthetic machinery are absent from human cells, peptidoglycan-binding proteins are high-value targets for antibiotics, and understanding their binding mechanisms directly informs resistance and drug-design research.
• Peptidoglycan binding is required for the transglycosylation and transpeptidation reactions that build the bacterial cell wall.
• PBPs are the lethal targets of beta-lactam antibiotics, so binding mechanism studies directly inform resistance and drug design.
• Host peptidoglycan recognition proteins use this function to detect bacterial infection and trigger innate immunity.
• Bacteriophage endolysins use cell-wall binding domains to recognize and degrade peptidoglycan, enabling phage lysis.
• Real-time and membrane-reconstituted assays now allow direct measurement of peptidoglycan binding and synthesis.
• Peptidoglycan-binding proteins are attractive antibacterial targets because they are essential in bacteria and absent in humans.
• Mycobacterial peptidoglycan binding is studied for tuberculosis-relevant phage and drug development.
• DAP-type peptidoglycan recognition links this function to insect and mammalian immune signalling.
• Structural and docking studies of endolysin binding domains guide engineering of improved antimicrobial enzymes.
• CRISPR-based perturbation of peptidoglycan-binding genes enables causal testing of their roles in growth and virulence.
Molecular Mechanism of peptidoglycan binding
Substrate recognition and initial docking
In simple terms: The protein first finds and loosely attaches to the sugar-and-peptide mesh of the bacterial cell wall.
Peptidoglycan-binding proteins recognize the sacculus through a combination of glycan and peptide contacts. PBPs and related enzymes contain modules that dock onto the glycan strands and stem peptides, positioning the catalytic domain for subsequent chemistry. Structural and biochemical work has shown that this initial docking is non-covalent and reversible, and that it can be monitored in real time using membrane-reconstituted systems. Docking studies of endolysin cell-wall binding domains further illustrate how conserved pockets engage peptidoglycan fragments.
Glycan strand engagement
In simple terms: The protein grips the sugar chains that form the backbone of the cell wall.
The glycan backbone of peptidoglycan consists of alternating N-acetylglucosamine and N-acetylmuramic acid residues. Peptidoglycan-binding modules, including those in PBPs and phage endolysins, form hydrogen-bond and hydrophobic contacts with these sugars, which contributes to affinity and specificity. Recognition of the glycan strand is often a prerequisite for correct positioning of catalytic residues that act on the peptide stems.
Peptide stem and cross-link recognition
In simple terms: The protein also reads the short peptide chains that tie the sugar strands together.
Stem peptides, including those containing DAP or lysine, are key determinants of peptidoglycan recognition. Preferential binding of DAP-type peptidoglycan by peptidoglycan recognition proteins has been demonstrated in insect hemolymph, showing that sequence-specific peptide recognition can discriminate bacterial cell wall chemotypes. PBPs likewise engage stem peptides during transpeptidation, and this interaction is the basis of beta-lactam inhibition.
Catalysis and remodelling
In simple terms: Once bound, the protein can cut or stitch the cell wall to allow growth and division.
After binding, PBPs catalyse transglycosylation and transpeptidation to extend and cross-link the sacculus, while hydrolases cleave specific bonds during remodelling. Real-time monitoring of peptidoglycan synthesis by membrane-reconstituted PBPs has provided direct kinetic evidence for these coupled binding and catalytic steps. Peptidoglycan recruitment by a PBP has also been visualized, clarifying how substrate is delivered to the active site.
Regulation and inhibition
In simple terms: Other molecules can block or tune this binding, which is how some antibiotics work.
Beta-lactam antibiotics act as substrate analogues that acylate PBPs, preventing productive peptidoglycan binding and cross-linking. Peptidoglycan biosynthesis and remodelling are tightly regulated in response to growth and stress, and this regulation determines when and where binding proteins act. Host and phage proteins add further layers of regulation by competing for or degrading peptidoglycan.
Key Genes Involved in GO:0042834 peptidoglycan binding
The following genes and protein families represent the principal peptidoglycan-binding functions described in the literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| pbpA / pbpB (E. coli) | Penicillin-binding proteins that catalyse peptidoglycan cross-linking | Core models for binding and beta-lactam inhibition studies |
| mrcA / mrcB | Class A PBPs with transglycosylase and transpeptidase activities | Real-time synthesis and binding assays |
| pbp2 / pbp3 | Essential PBPs for elongation and division | Targets of beta-lactams and cell shape studies |
| PGRP-SA / PGRP-SD | Peptidoglycan recognition proteins in innate immunity | DAP-type peptidoglycan binding and immune signalling |
| PGRP-LC | Membrane peptidoglycan receptor | Host detection of bacterial infection |
| Lysostaphin | Endolysin with peptidoglycan-binding and catalytic domains | Antimicrobial enzyme engineering |
| LysK / mycophage endolysins | Cell-wall binding domains targeting mycobacterial peptidoglycan | Tuberculosis-relevant binding studies |
| PlyB / PlyG | Phage endolysins with cell-wall binding domains | Docking and mechanism studies |
| DacA / DacB | Low-molecular-weight PBPs with DD-carboxypeptidase activity | Peptidoglycan remodelling and binding |
| MltA / MltB | Lytic transglycosylases that bind peptidoglycan | Cell wall turnover and binding assays |
| AmiA / AmiB | Amidases that cleave peptidoglycan stem peptides | Remodelling and binding specificity |
| Slt70 | Soluble lytic transglycosylase | Peptidoglycan binding and turnover |
| PonA / PonB | Elongasome-associated PBPs | Cell elongation and binding dynamics |
| FtsI | Division-specific PBP | Septal peptidoglycan binding |
| PBP4 (S. aureus) | Low-affinity PBP linked to resistance | Beta-lactam resistance and binding studies |
| PBP2a (mecA) | Methicillin-resistant PBP | Resistance mechanism and inhibitor design |
| PGRP-LE | Intracellular peptidoglycan sensor | Autophagy and immune signalling |
| Endolysin CBDs | Cell-wall binding domains | Engineering specificity for bacterial targets |
How Is peptidoglycan binding Regulated?
Peptidoglycan binding is regulated at multiple levels. In bacteria, the activity and localization of PBPs and remodelling enzymes are controlled by growth phase, cell cycle cues and stress responses, ensuring that wall synthesis is coordinated with division. Beta-lactam antibiotics act as competitive inhibitors that acylate PBPs and block productive peptidoglycan binding. In host organisms, peptidoglycan recognition proteins are regulated as part of innate immune signalling, with DAP-type peptidoglycan preferentially triggering specific pathways. Phage endolysin binding domains are regulated by phage lytic cycle timing and can be engineered for altered specificity.
peptidoglycan binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| mecA / PBP2a | Methicillin-resistant Staphylococcus aureus | Point-mutation and knock-in of mecA in S. aureus |
| pbpA / pbpB | Beta-lactam susceptibility and cell wall integrity | CRISPR knockout in E. coli and phenotypic profiling |
| PGRP-SA | Innate immune deficiency and bacterial sensing | Knockout in Drosophila or mammalian immune cells |
| LysK / mycophage CBD | Mycobacterial infection and phage therapy | Binding-domain knock-in and activity assays |
| PBP4 | Staphylococcal resistance and virulence | Overexpression and point-mutation models |
Antibiotic resistance and bacterial infection
Peptidoglycan-binding PBPs are the targets of beta-lactam antibiotics, and mutations or acquisition of alternative PBPs such as PBP2a confer resistance in clinically important pathogens. Understanding how these proteins bind peptidoglycan is therefore central to overcoming resistance and designing new inhibitors.
Host innate immunity and inflammation
Peptidoglycan recognition proteins detect bacterial cell wall fragments and initiate immune signalling. Preferential binding of DAP-type peptidoglycan by insect PGRPs illustrates how this molecular function discriminates bacterial chemotypes and shapes downstream immune responses.
Phage therapy and antimicrobial enzymes
Endolysins use peptidoglycan-binding domains to recognize and degrade bacterial cell walls, making them promising antimicrobial agents. Docking and characterization studies of endolysin binding domains support engineering of enzymes with improved specificity, including against mycobacteria.
Tuberculosis and mycobacterial cell wall biology
Mycobacterial peptidoglycan biosynthesis and remodelling are essential for growth and virulence, and peptidoglycan-binding proteins are being explored as drug targets. Mycophage endolysin cell-wall binding domains that target Mycobacterium bovis peptidoglycan provide tools for detection and therapy.
From peptidoglycan binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for peptidoglycan binding? | CRISPR knockout cell line or bacterial strain |
| Does a specific residue mediate substrate recognition? | Point-mutation knock-in of the binding pocket |
| Can a tagged protein report binding dynamics? | Tagged knock-in with fluorescent or affinity tag |
| Does overexpression alter cell wall synthesis? | Inducible overexpression construct |
| Which genes modify beta-lactam susceptibility? | CRISPR library screening with antibiotic selection |
| How does a binding domain recognize peptidoglycan? | Recombinant domain expression and binding assays |
How to Study the peptidoglycan binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Affinity pull-down | Direct protein-peptidoglycan interaction | Identifying new binding proteins |
| Surface plasmon resonance | Binding affinity and kinetics | Comparing wild-type and mutant domains |
| Membrane-reconstituted synthesis assay | Real-time peptidoglycan synthesis | PBP mechanism studies |
| Molecular docking | Predicted binding poses | Endolysin domain engineering |
| CRISPR knockout phenotyping | Requirement of a gene for binding or growth | Target validation |
| Point-mutation knock-in | Role of specific residues | Binding pocket dissection |
| Fluorescence microscopy | Localization of tagged binding proteins | Cell wall synthesis site mapping |
| Antibiotic susceptibility testing | Functional impact of binding inhibition | Resistance and drug studies |
Binding and activity assays
Direct peptidoglycan binding can be measured with purified proteins or domains using affinity pull-downs, surface plasmon resonance and fluorescence polarization. Real-time monitoring of peptidoglycan synthesis by membrane-reconstituted PBPs provides kinetic readouts of binding and catalysis. Docking studies complement these assays by predicting binding poses for endolysin domains.
Structural biology and modelling
Crystal structures and homology models of PBPs and endolysin cell-wall binding domains reveal the residues that contact glycan and peptide moieties. These structural data explain substrate specificity and guide inhibitor design.
Genetic perturbation and phenotyping
CRISPR knockout, point mutation and overexpression are used to test the requirement of candidate genes for peptidoglycan binding and cell wall integrity. Phenotypic readouts include growth rate, morphology, antibiotic susceptibility and cell wall labelling.
Immune and host interaction assays
Peptidoglycan recognition proteins can be studied in immune cell models using purified peptidoglycan chemotypes to measure binding specificity and downstream signalling. DAP-type peptidoglycan binding assays in insect hemolymph illustrate this approach.
How CRISPR Can Be Used to Study GO:0042834 peptidoglycan binding
Knockout
CRISPR knockout of candidate peptidoglycan-binding genes, such as pbpA or PGRP homologues, allows direct testing of their requirement for cell wall synthesis, bacterial growth or immune detection. Knockout strains can be profiled for growth, morphology and antibiotic susceptibility to assign function.
Point Mutation
Point-mutation knock-in of residues predicted to contact peptidoglycan enables precise dissection of binding determinants. This approach is valuable for testing structural predictions from PBP and endolysin domain models.
Knock-in
Tagged knock-in of peptidoglycan-binding proteins with fluorescent or affinity tags supports live-cell localization and interaction studies. Knock-in of alternative PBPs such as mecA can also model resistance phenotypes.
Overexpression
Inducible overexpression of peptidoglycan-binding proteins or their binding domains can reveal dominant phenotypes, saturate binding partners or produce recombinant protein for biochemical assays.
How EDITGENE Supports peptidoglycan binding Research
Researchers studying peptidoglycan binding-related genes often need to determine whether a candidate gene is causally involved in substrate recognition, cell wall integrity or host detection. EDITGENE provides end-to-end CRISPR cell model generation and screening services to convert correlative observations into mechanistic evidence.
Contact EDITGENE today to design your custom CRISPR model for peptidoglycan binding research.
Frequently Asked Questions About peptidoglycan binding
What is peptidoglycan binding?
Peptidoglycan binding (GO:0042834) is the selective, non-covalent interaction of a protein with peptidoglycan, the glycoconjugate scaffold of bacterial cell walls.
What genes are involved in peptidoglycan binding?
Key genes include penicillin-binding proteins such as pbpA, pbpB, mrcA and mrcB, peptidoglycan recognition proteins such as PGRP-SA, and phage endolysin cell-wall binding domains.
What is the GO ID for peptidoglycan binding?
The Gene Ontology identifier is GO:0042834, under the molecular_function aspect.
How do penicillin-binding proteins bind peptidoglycan?
PBPs dock onto glycan strands and stem peptides through non-covalent contacts, then catalyse transglycosylation and transpeptidation; this binding is blocked by beta-lactam antibiotics.
Why is peptidoglycan binding important for antibiotics?
Because PBPs must bind peptidoglycan to build the cell wall, blocking this interaction with beta-lactams is lethal to many bacteria, making it a central antibiotic target.
Do human cells have peptidoglycan-binding proteins?
Humans lack peptidoglycan but express peptidoglycan recognition proteins that detect bacterial cell wall fragments as part of innate immunity.
How can I study peptidoglycan binding in the lab?
Common approaches include affinity pull-downs, surface plasmon resonance, membrane-reconstituted synthesis assays, molecular docking and CRISPR-based perturbation.
What are phage endolysin cell-wall binding domains?
They are modules within bacteriophage endolysins that recognize and bind peptidoglycan, targeting the enzyme to the bacterial cell wall for degradation.
Is peptidoglycan binding involved in tuberculosis?
Mycobacterial peptidoglycan biosynthesis and remodelling are essential, and mycophage endolysin binding domains that target Mycobacterium bovis peptidoglycan are being studied for detection and therapy.
What CRISPR models are used for peptidoglycan binding research?
Knockout, point-mutation, knock-in, tagged knock-in and overexpression models are used to test gene requirement, residue function, localization and gain-of-function effects.
Conclusion
GO:0042834 peptidoglycan binding defines a fundamental molecular function that underpins bacterial cell wall synthesis, host immune detection and phage lysis. The penicillin-binding proteins remain the best-studied examples, and their binding mechanisms are directly relevant to antibiotic action and resistance. Emerging real-time and structural approaches continue to refine our understanding of how proteins recognize this complex glycoconjugate. Because peptidoglycan-binding proteins are essential in bacteria and absent from human cells, they remain a high-value target space for antibacterial discovery and biotechnology. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with binding and screening assays, provide the causal evidence needed to translate this molecular function into new therapeutic strategies.
References
- 1. Sauvage E et al.. 2008. The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis.. FEMS Microbiol Rev 32(2):234-58 PMID: 18266856
- 2. Hunashal Y et al.. 2025. Peptidoglycan recruitment by a penicillin binding protein.. Nat Commun 16(1):11244 PMID: 41407687
- 3. Arakelian AG et al.. 2024. Molecular Docking of Endolysins for Studying Peptidoglycan Binding Mechanism.. Molecules 29(22) PMID: 39598776
- 4. Itterbeek A et al.. 2023. Characterization of mycophage endolysin cell wall binding domains targeting Mycobacterium bovis peptidoglycan.. Biochem Biophys Res Commun 681:291-297 PMID: 37801778
- 5. Kariyawasam U et al.. 2022. Preferential binding of DAP-PGs by major peptidoglycan recognition proteins found in cell-free hemolymph of Manduca sexta.. Insect Biochem Mol Biol 148:103827 PMID: 36007680
- 6. Hernández-Rocamora VM et al.. 2021. Real-time monitoring of peptidoglycan synthesis by membrane-reconstituted penicillin-binding proteins.. Elife 10 PMID: 33625355
- 7. Shaku M et al.. 2020. Peptidoglycan biosynthesis and remodeling revisited.. Adv Appl Microbiol 112:67-103 PMID: 32762868
- 8. Rodríguez-Tébar A et al.. 1984. Penicillin-binding proteins and peptidoglycan peptide-interacting proteins.. Microbiol Sci 1(9):211-4 PMID: 6444131
